Analyst Reco. agilon health, inc.

Equities

AGL

US00857U1079

Market Closed - Nyse Other stock markets 04:00:03 2024-05-31 pm EDT			5-day change	1st Jan Change
6.3 ^USD	+0.96%		+3.45%	-49.80%

May. 30	Baird Starts agilon health With Neutral Rating, $6 Price Target	MT
May. 24	Truist Lifts Price Target on agilon health to $6.50 From $6.40, Maintains Hold Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Baird Starts agilon health With Neutral Rating, $6 Price Target	May. 30	MT
Truist Lifts Price Target on agilon health to $6.50 From $6.40, Maintains Hold Rating	May. 24	MT
Deutsche Bank Adjusts agilon health Price Target to $5 From $8, Maintains Hold Rating	May. 09	MT
Citigroup Starts agilon health With Neutral Rating, $6 Price Target	Apr. 22	MT
Barclays Initiates Agilon Health With Underweight Rating, Price Target is $5	Mar. 06	MT
Deutsche Bank Cuts Agilon Health's Price Target to $8 From $10, Maintains Hold Rating	Feb. 29	MT
Truist Securities Cuts Price Target on Agilon Health to $7.50 From $10, Maintains Hold Rating	Feb. 29	MT
RBC Cuts Price Target on Agilon Health to $8 From $11, Says Near Term 'Could Remain Choppy,' Keeps Outperform Rating	Feb. 28	MT
TD Cowen Downgrades Agilon Health to Market Perform From Outperform	Feb. 26	MT
Deutsche Bank Adjusts Price Target on Agilon Health to $10 From $12, Maintains Hold Rating	Jan. 08	MT
Wolfe Research Downgrades Agilon Health to Peer Perform From Outperform	Jan. 08	MT
JPMorgan Downgrades Agilon Health to Neutral From Overweight, Cuts Price Target to $9 From $17	Jan. 05	MT
Goldman Sachs Downgrades Agilon Health to Neutral From Buy, Cuts Price Target to $14 From $22	Dec. 11	MT
JMP Securities Initiates Agilon Health With Market Outperform Rating, Price Target is $18	Dec. 06	MT
Deutsche Bank Downgrades Agilon Health to Hold From Buy, Adjusts Price Target to $12 From $27	Nov. 21	MT
Benchmark Adjusts agilon health's Price Target to $22 From $28, Keeps Buy Rating	Nov. 15	MT
Wells Fargo Adjusts agilon health's Price Target to $16 From $23, Keeps Overweight Rating	Nov. 13	MT
Goldman Sachs Cuts Price Target on agilon health to $22 From $25, Maintains Buy Rating	Nov. 09	MT
RBC Cuts Price Target on agilon health to $23 From $28, Keeps Outperform Rating	Nov. 03	MT
TD Cowen Adjusts agilon health's Price Target to $25 From $29, Keeps Outperform Rating	23-08-15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. agilon health, inc.

Equities

AGL

US00857U1079

Analyst Reco.

Filters